Provided herein are methods and compositions related to a retinoid receptor-selective pathway. As described herein, this pathway can be targeted to manipulate a tumor microenvironment. For example, the methods and compositions described herein can be used to induce apoptosis in a cancer cell. Further, the compositions described herein, including Sulindac and analogs thereof, can be used to target this pathway for the treatment or prevention of cancer in human patients.
本文提供了与
视黄醛受体选择性通路相关的方法和组合物。如本文所述,该通路可以被定向用于操纵肿瘤微环境。例如,本文描述的方法和组合物可用于诱导癌细胞凋亡。此外,包括舒林达克及其类似物在内的本文描述的组合物可用于针对该通路治疗或预防人类患者的癌症。